Baseline levels of CHIT1, CHI3L1, CHI3L2, and CHIT1 activity were significantly higher in participants with symptomatic ALS than controls and asymptomatic gene carriers, controlling for age. The gene discussed is CHI3L2; the disease is amyotrophic lateral sclerosis.